Intravenous Infusion of an Antisense Oligonucleotide Results in Exon Skipping in Muscle Dystrophin mRNA of Duchenne Muscular Dystrophy

Pediatric Research- United States

doi 10.1203/01.pdr.0000215047.51278.7c

Full Text

Abstract

Available in

Date

Authors

Publisher

Springer Science and Business Media LLC

Related search

Dual Exon Skipping in Myostatin and Dystrophin for Duchenne Muscular Dystrophy

BMC Medical Genomics
Genetics
2011English

Antisense Oligo-Mediated Multiple Exon Skipping in a Dog Model of Duchenne Muscular Dystrophy

Methods in Molecular Biology
GeneticsMolecular Biology
2010English

A Multicenter Comparison of Quantification Methods for Antisense Oligonucleotide-Induced DMD Exon 51 Skipping in Duchenne Muscular Dystrophy Cell Cultures

PLoS ONE
Multidisciplinary
2018English

136. First-In-Human Study of NS-065/NCNP-01; The Morpholino Based Antisense Oligonucleotide for Exon 53 Skipping in Duchenne Muscular Dystrophy

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2015English

Wild-Type Mouse Models to Screen Antisense Oligonucleotides for Exon-Skipping Efficacy in Duchenne Muscular Dystrophy

PLoS ONE
Multidisciplinary
2014English

Exon Skipping: A First in Class Strategy for Duchenne Muscular Dystrophy

Expert Opinion on Biological Therapy
Drug DiscoveryClinical BiochemistryPharmacology
2016English

Efficacy of Multi-Exon Skipping Treatment in Duchenne Muscular Dystrophy Dog Model Neonates

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2019English

Prednisolone Treatment Does Not Interfere With 2′-O-Methyl Phosphorothioate Antisense-Mediated Exon Skipping in Duchenne Muscular Dystrophy

Human Gene Therapy
Molecular MedicineGeneticsMolecular Biology
2012English

Antisense-Induced Exon Skipping and Synthesis of Dystrophin in the MDX Mouse

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2001English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy